tiprankstipranks
Advertisement
Advertisement
Exicure to present data from burixafor Phase 2 trial at 2026 Tandem Meetings
PremiumThe FlyExicure to present data from burixafor Phase 2 trial at 2026 Tandem Meetings
2M ago
Exicure presents topline data from burixafor combination trial
Premium
The Fly
Exicure presents topline data from burixafor combination trial
4M ago
Exicure Inc trading resumes
Premium
The Fly
Exicure Inc trading resumes
4M ago
Exicure announces near-term strategic priorities
PremiumThe FlyExicure announces near-term strategic priorities
6M ago
Exicure Regains Nasdaq Compliance as of July 2025
Premium
Company Announcements
Exicure Regains Nasdaq Compliance as of July 2025
8M ago
Exicure completes last patient in Phase 2 GPC-100 combo trial
Premium
The Fly
Exicure completes last patient in Phase 2 GPC-100 combo trial
8M ago
Exicure receives Nasdaq delinquency notice on late Form 10-Q filing
PremiumThe FlyExicure receives Nasdaq delinquency notice on late Form 10-Q filing
10M ago
Exicure Delays 10-Q Filing Amid Acquisition
Premium
Company Announcements
Exicure Delays 10-Q Filing Amid Acquisition
11M ago
Exicure Enters Convertible Bond Agreement with Subsidiary
Premium
Company Announcements
Exicure Enters Convertible Bond Agreement with Subsidiary
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100